Skip to content
AnalystLens

James Hardie Industries 8-K Report (Feb 20, 2026)

Filing Date
Filed February 20, 2026
Period End
February 20, 2026
Securities
JHXJHIUF
In the record · 2016–202610-K1210-Q18-K401

JHX filed 12 annual reports (10-K), 1 quarterly reports (10-Q) and 401 current reports (8-K) between 2016 and 2026.

Summary

Summary of the 6-K filed February 20, 2026. Cited figures are marked; the original filing is the authoritative source.

James Hardie Industries plc (JHX) filed this Form 6-K on February 20, 2026.

The filing contains no earnings, guidance, or transaction announcements. Instead, it bundles seven exhibits that are mostly regulatory notices: ASX Appendix 3G notifications of unquoted equity securities, an Appendix 3Y director's interest notice, and a substantial holding notice. It also includes the company's standard forward-looking statements caution.

The equity notices show routine issuance of unquoted securities. Exhibit 99.1 reports a grant of 85,742 restricted stock units to Jonathan Skelly under the James Hardie Industries Equity Incentive Plan 2001, issued February 9, 2026. Exhibits 99.2, 99.5, 99.6 and 99.7 report issuances of ordinary shares on February 9, 11, 12 and 13, 2026 (520, 17,497, 1,027 and 33,100 shares respectively) at issue prices between USD 0.6997 and USD 0.7032.

These relate to the settlement of certain AZEK equity awards following the July 1, 2025 merger. Shares on issue were 430,436,032 CHESS Depositary Interests and 149,695,139 unquoted ordinary shares as of the last notice. On the ownership side, director Jesse Singh disposed of 400,000 ordinary shares on February 12, 2026 for USD 10,447,120 through an on-market sale by The Jesse G.

Singh Revocable Trust. A substantial holding notice shows FMR LLC crossed the 3%a threshold on February 11, 2026, with a resulting holding of 3.0323% of voting rights (17,588,940 shares) against 580,062,173 total voting rights.

Key Highlights

  1. Filing is a set of ASX regulatory notices rather than financial results or guidance; no earnings figures are reported.
  2. CEO-level equity activity: 85,742 restricted stock units granted to Jonathan Skelly on February 9, 2026 under the 2001 Plan.
  3. Post-AZEK merger share settlement: ordinary shares issued February 9–13, 2026 (520; 17,497; 1,027; 33,100) at USD 0.6997–0.7032 per share.
  4. Director sale: Jesse Singh's revocable trust sold 400,000 ordinary shares on February 12, 2026 for USD 10,447,120.
  5. Substantial holder: FMR LLC's voting interest reached 3.0323% (17,588,940 shares) on February 11, 2026, up from 2.7133%.
  6. Share count: 430,436,032 CHESS Depositary Interests quoted on ASX; unquoted ordinary shares rose to 149,695,139 by February 13, 2026 across the notices.

Frequently Asked Questions

  1. Does this filing include new financial results or guidance?

    No. The filing contains only regulatory exhibits: ASX equity issuance notices, a director dealing notice, a substantial holding notice, and standard forward-looking statement cautions. It does not report operating or financial results.

  2. Why are shares being issued to settle equity awards?

    The notices state that the issued ordinary shares represent settlement of certain AZEK equity awards outstanding at the closing of the merger consummated on July 1, 2025, under the Agreement and Plan of Merger with The AZEK Company Inc.

  3. Was the director's share sale significant?

    The filing reports that Jesse Singh's trust sold 400,000 ordinary shares on February 12, 2026 for USD 10,447,120, reducing the trust's holding from 555,471 to 155,471 shares. His direct and other indirect holdings were unchanged.

  4. What does the FMR LLC notification mean for investors?

    FMR LLC disclosed that its holding crossed the 3% threshold on February 11, 2026, at 3.0323% of voting rights, up from 2.7133% previously. The filing attributes the change to a stock merger following M&A completion.